San Sac förvärvar danska Rubaek & Co
Linköpingsföretaget San Sac tar steget in på den danska marknaden via förvärv av det danska bolaget Rubaek & Co.
Linköpingsföretaget San Sac tar steget in på den danska marknaden via förvärv av det danska bolaget Rubaek & Co.
ByggPartner, of Dalecarlia, central Sweden, and Stockholm-based building contractor BOL Entreprenad are merging to create a new and competitive construction group in central Sweden.
September 1, 2010, Mats Warstedt takes on the position as CEO of Innovativ Vision AB in Sweden, the world´s leading supplier of the WoodEye scanning equipment for the wood processing industry.
Priveq Investment is becoming a partner of Mediplast AB, a leader in consumables for healthcare. In 2009, Mediplast had sales of approximately SEK 310 m and has traced high growth through recent years. In tandem with Priveq’s investment, capital is also being injected into Mediplast to further accelerate its rate of expansion. The company’s current principal owner, Procurator AB, is remaining as a
Priveq Investment blir ny delägare i Mediplast AB, ett ledande företag inom förbrukningsartiklar avsedda för sjukvården. Mediplast hade under 2009 en omsättning om cirka 310 Mkr och har uppvisat en stark tillväxt under de senaste åren. I samband med Priveqs investering tillförs även Mediplast kapital för att ytterligare öka expansionstakten.
-“In the midst of a tough exit market, we achieved our best exit ever and contributed to the creation of a new Swedish specialist pharmaceutical company with great international potential,” said Louise Nilsson, Partner and Investment Manager of Priveq Investment.
Fredrik Jaginder har rekryterats till ny VD i Linköpingsföretaget San Sac AB. Fredrik Jaginder är 44 år och kommer närmast från ventilföretaget NAF AB där han arbetat som marknads- och försäljningsansvarig. Fredrik Jaginder tillträder sin tjänst den 18 januari.
Priveq investment has as of today closed the exit transaction made on November 5th, 2009, thus sealing the outcome of the most successful exit, money multiple-wise, of our 27 years of history. The transaction was conditioned by a positive outcome in the Biovitrum EGM as of December 4th 2009.
Thereby concluding a >26x-investment, excluding a possible additional 3x dependant on further company